1. Home
  2. UE vs CLDX Comparison

UE vs CLDX Comparison

Compare UE & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UE
  • CLDX
  • Stock Information
  • Founded
  • UE 2014
  • CLDX 1983
  • Country
  • UE United States
  • CLDX United States
  • Employees
  • UE N/A
  • CLDX N/A
  • Industry
  • UE Real Estate
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • UE Finance
  • CLDX Health Care
  • Exchange
  • UE Nasdaq
  • CLDX Nasdaq
  • Market Cap
  • UE 2.4B
  • CLDX 2.9B
  • IPO Year
  • UE N/A
  • CLDX 2008
  • Fundamental
  • Price
  • UE $22.00
  • CLDX $28.74
  • Analyst Decision
  • UE Hold
  • CLDX Buy
  • Analyst Count
  • UE 2
  • CLDX 8
  • Target Price
  • UE $20.00
  • CLDX $64.83
  • AVG Volume (30 Days)
  • UE 770.4K
  • CLDX 1.5M
  • Earning Date
  • UE 10-30-2024
  • CLDX 10-31-2024
  • Dividend Yield
  • UE 3.09%
  • CLDX N/A
  • EPS Growth
  • UE 1684.81
  • CLDX N/A
  • EPS
  • UE 2.46
  • CLDX N/A
  • Revenue
  • UE $424,588,000.00
  • CLDX $8,303,000.00
  • Revenue This Year
  • UE N/A
  • CLDX N/A
  • Revenue Next Year
  • UE $0.80
  • CLDX N/A
  • P/E Ratio
  • UE $8.94
  • CLDX N/A
  • Revenue Growth
  • UE 6.58
  • CLDX 155.16
  • 52 Week Low
  • UE $14.36
  • CLDX $22.11
  • 52 Week High
  • UE $22.29
  • CLDX $53.18
  • Technical
  • Relative Strength Index (RSI)
  • UE 65.98
  • CLDX 31.50
  • Support Level
  • UE $20.97
  • CLDX $29.22
  • Resistance Level
  • UE $22.29
  • CLDX $31.66
  • Average True Range (ATR)
  • UE 0.35
  • CLDX 1.45
  • MACD
  • UE 0.06
  • CLDX -0.17
  • Stochastic Oscillator
  • UE 80.97
  • CLDX 5.57

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Share on Social Networks: